Digital transformation expected to shorten drug development timelines

Digital transformation expected to shorten drug development timelines

A survey by GlobalData shows that 82% of pharmaceutical professionals believe digital transformation will shorten drug development timelines. AI is seen as the most disruptive technology, with many anticipating significant benefits in areas like target identification and lead generation.

Read More

Did you find this insightful?